Just-published research in Cell outlines a way to make even immunotherapy-resistant cancers treatable. Further studies are required, but the finding suggests an approach that would enable vast numbers of patients to benefit from immunotherapy who currently cannot.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,